MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 49 filers reported holding MEI PHARMA INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $894,000 | -12.7% | 307,313 | -4.9% | 0.00% | -100.0% |
| Q2 2021 | $1,024,000 | +31.5% | 323,089 | +37.6% | 0.00% | 0.0% |
| Q1 2021 | $779,000 | +1.4% | 234,731 | -8.3% | 0.00% | 0.0% |
| Q4 2020 | $768,000 | +5020.0% | 255,843 | +5267.0% | 0.00% | – |
| Q3 2020 | $15,000 | -46.4% | 4,767 | -42.2% | 0.00% | – |
| Q2 2020 | $28,000 | +21.7% | 8,242 | -9.3% | 0.00% | – |
| Q4 2019 | $23,000 | +130.0% | 9,085 | +51.9% | 0.00% | – |
| Q3 2019 | $10,000 | -28.6% | 5,979 | +5.1% | 0.00% | – |
| Q2 2019 | $14,000 | -88.1% | 5,688 | -87.0% | 0.00% | – |
| Q3 2017 | $118,000 | -6.3% | 43,816 | -17.2% | 0.00% | – |
| Q2 2017 | $126,000 | +6200.0% | 52,892 | +17530.7% | 0.00% | – |
| Q2 2014 | $2,000 | -97.2% | 300 | -95.3% | 0.00% | – |
| Q1 2014 | $71,000 | +39.2% | 6,326 | 0.0% | 0.00% | – |
| Q4 2013 | $51,000 | -10.5% | 6,326 | +25.3% | 0.00% | – |
| Q3 2013 | $57,000 | +58.3% | 5,048 | 0.0% | 0.00% | – |
| Q2 2013 | $36,000 | – | 5,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |